Cowen and Company’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Cowen and Company’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-739,320	Closed	-$8.1M	–	778
2023 Q3	$8.1M	Buy	739,320 +684,960	+1,260%	+$7.44M	0.57%	41
2023 Q2	$583K	Buy	+54,360	New	+$576K	0.05%	171

Cowen and Company's FRBN Position: Q4 2023 in Review

Cowen and Company sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 739,320 shares — an estimated $8.1M sold.

Cowen and Company first reported a position in FRBN in Q2 2023 and held it in 2 quarters. The position peaked at $8.1M in Q3 2023. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

Cowen and Company reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Cowen and Company sold 739,320 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $8.1M.
Cowen and Company first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q2 2023 and held it in 2 quarters.
Cowen and Company's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $8.1M in Q3 2023.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.